Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4). Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, e...
The Acromegaly is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.1% during the forecast period. The research provides insights for the global Acromegaly market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail....
The Transforming Growth Factor Beta 2 is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.0% during the forecast period. The research provides insights for the global Transforming Growth Factor Beta 2 market based on different Types, End-Users and Regions, and competitive lands...
The Ultra-low Molecular Weight Heparin (ULMWH) is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period. The research provides insights for the global Ultra-low Molecular Weight Heparin (ULMWH) market based on different Types, End-Users and Regions, and...
The Cervical Cancer Treatment is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period. The research provides insights for the global Cervical Cancer Treatment market based on different Types, End-Users and Regions, and competitive landscape of these se...
The Melanoma Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. The research provides insights for the global Melanoma Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in...
The central nervous system (CNS) is the part of thenervous system consisting of the brain and spinal cord. The Central Nervous System Therapeutic is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. The research provides insights for the global Cen...
Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. The Adenosine Deaminase Deficiency Therapeutic is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.7% during t...
Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. It has been observed that out of all the leukemia’s, hairy cell leukemia accounts for about 2% and thus eventually must be treated after its prominent symptoms. The drivers for the HCL market can be the rural or country side population which i...
The Toxoid is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period. The research provides insights for the global Toxoid market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail. A wide ...
The Sotalol Drug is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The research provides insights for the global Sotalol Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in det...
The Hypertrophic Cardiomyopathy (HCM) Therapeutics is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period. The research provides insights for the global Hypertrophic Cardiomyopathy (HCM) Therapeutics market based on different Types, End-Users and Regi...
The Rhizoma Gastrodiae Tablets is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period. The research provides insights for the global Rhizoma Gastrodiae Tablets market based on different Types, End-Users and Regions, and competitive landscape of these ...
The Ophthalmic Therapeutic Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.6% during the forecast period. The research provides insights for the global Ophthalmic Therapeutic Drugs market based on different Types, End-Users and Regions, and competitive landscape of th...
The Spine Osteoarthritis Pain Drug is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period. The research provides insights for the global Spine Osteoarthritis Pain Drug market based on different Types, End-Users and Regions, and competitive landscape o...
The Fanconi Anemia Drug is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period. The research provides insights for the global Fanconi Anemia Drug market based on different Types, End-Users and Regions, and competitive landscape of these segments are a...
The Metastatic Uveal Melanoma Thereapeutics is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period. The research provides insights for the global Metastatic Uveal Melanoma Thereapeutics market based on different Types, End-Users and Regions, and compe...
The Vegetable Capsules is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period. The research provides insights for the global Vegetable Capsules market based on different Types, End-Users and Regions, and competitive landscape of these segments are ana...
The Consumer Healthcare is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period. The research provides insights for the global Consumer Healthcare market based on different Types, End-Users and Regions, and competitive landscape of these segments are a...
The Lymphocyte Activation Gene 3 Protein is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period. The research provides insights for the global Lymphocyte Activation Gene 3 Protein market based on different Types, End-Users and Regions, and competitive...
Chinese